Sectors
BCYC
Bicycle Therapeutics plc
3.65
2 x 2.67
2 x 4.68
bid
ask
-
0.03
0.82%
2 @ 07:30 PM
3.65 +0.00 (0.00%)
| Ytd | -48.45% | |
| 1y | -49.02% |
3.63
day range
3.70
3.60
52 week range
9.16
| Open | 3.69 | Prev Close | 3.68 | Low | 3.63 | High | 3.70 | Mkt Cap | 255.47M |
| Vol | 240.42K | Avg Vol | 373.19K | EPS | -2.73 | P/E | N/A | Forward P/E | -3.09 |
| Beta | 0.93 | Short Ratio | 14.44 | Inst. Own | 92.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 4.07 | 200-d Avg | 5.06 | 1yr Est | 29.55 |
| Income Statement | |||
| Total Revenue | 629.00K | ||
| Revenues (USD) | 629.00K | ||
| Gross Profit | 629.00K | ||
| Operating Expenses | 55.19M | ||
| Research and Development Expense | 41.16M | ||
| Selling, General and Administrative Expense | 14.03M | ||
| Operating Income | -54.56M | ||
| Interest Expense | 44.00K | ||
| Income Tax Expense | 90.00K | ||
| Net Income | -50.33M | ||
| Net Income Common Stock | -50.33M | ||
| Net Income Common Stock (USD) | -50.33M | ||
| Consolidated Income | -50.33M | ||
| Earnings per Basic Share | -0.72 | ||
| Earnings per Basic Share (USD) | -0.72 | ||
| Earnings per Diluted Share | -0.72 | ||
| Earning Before Interest & Taxes (EBIT) | -50.20M | ||
| Earning Before Interest & Taxes (USD) | -50.20M | ||
| Weighted Average Shares | 69.80M | ||
| Weighted Average Shares Diluted | 69.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 510.05M | ||
| Cash and Equivalents (USD) | 510.05M | ||
| Trade and Non-Trade Receivables | 47.42M | ||
| Current Assets | 575.24M | ||
| Property, Plant & Equipment Net | 18.67M | ||
| Total Assets | 606.58M | ||
| Total Debt | 13.68M | ||
| Current Liabilities | 47.64M | ||
| Debt Non-Current | 13.68M | ||
| Total Liabilities | 96.32M | ||
| Accumulated Retained Earnings (Deficit) | -1.01B | ||
| Accumulated Other Comprehensive Income | -5.42M | ||
| Shareholders Equity | 510.26M | ||
| Shareholders Equity (USD) | 510.26M | ||
| Assets Non-Current | 31.34M | ||
| Total Debt (USD) | 13.68M | ||
| Deferred Revenue | 36.96M | ||
| Liabilities Non-Current | 48.69M | ||
| Trade and Non-Trade Payables | 5.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.07M | ||
| Net Cash Flow from Financing | -50.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -49.97M | ||
| Capital Expenditure | -265.00K | ||
| Issuance (Purchase) of Equity Shares | 1000 | ||
| Issuance (Repayment) of Debt Securities | -51.00K | ||
| Net Cash Flow from Investing | -265.00K | ||
| Net Cash Flow from Operations | -49.61M | ||
| Effect of Exchange Rate Changes on Cash | -49.00K | ||
| Share Based Compensation | 6.40M | ||